PS155. Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies

Detalles Bibliográficos
Autores principales: Nelson, Craig, Skuban, Aleksandar, Zhang, Peter, Weiller, Emmanuelle, Weiss, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616751/
http://dx.doi.org/10.1093/ijnp/pyw043.155
_version_ 1783266856373583872
author Nelson, Craig
Skuban, Aleksandar
Zhang, Peter
Weiller, Emmanuelle
Weiss, Catherine
author_facet Nelson, Craig
Skuban, Aleksandar
Zhang, Peter
Weiller, Emmanuelle
Weiss, Catherine
author_sort Nelson, Craig
collection PubMed
description
format Online
Article
Text
id pubmed-5616751
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56167512017-11-27 PS155. Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies Nelson, Craig Skuban, Aleksandar Zhang, Peter Weiller, Emmanuelle Weiss, Catherine Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616751/ http://dx.doi.org/10.1093/ijnp/pyw043.155 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Nelson, Craig
Skuban, Aleksandar
Zhang, Peter
Weiller, Emmanuelle
Weiss, Catherine
PS155. Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies
title PS155. Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies
title_full PS155. Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies
title_fullStr PS155. Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies
title_full_unstemmed PS155. Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies
title_short PS155. Long-term safety of adjunctive brexpiprazole (OPC-34712) in MDD: results from two 52-week open-label studies
title_sort ps155. long-term safety of adjunctive brexpiprazole (opc-34712) in mdd: results from two 52-week open-label studies
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616751/
http://dx.doi.org/10.1093/ijnp/pyw043.155
work_keys_str_mv AT nelsoncraig ps155longtermsafetyofadjunctivebrexpiprazoleopc34712inmddresultsfromtwo52weekopenlabelstudies
AT skubanaleksandar ps155longtermsafetyofadjunctivebrexpiprazoleopc34712inmddresultsfromtwo52weekopenlabelstudies
AT zhangpeter ps155longtermsafetyofadjunctivebrexpiprazoleopc34712inmddresultsfromtwo52weekopenlabelstudies
AT weilleremmanuelle ps155longtermsafetyofadjunctivebrexpiprazoleopc34712inmddresultsfromtwo52weekopenlabelstudies
AT weisscatherine ps155longtermsafetyofadjunctivebrexpiprazoleopc34712inmddresultsfromtwo52weekopenlabelstudies

Ejemplares similares